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Evaluation of the Antimicrobial Activity of Natural Animal Proteins/
Peptides In Vitro
Abstract
The objectives of this research were to validate the sensitivity and precision of an in vitro assay for evaluating
the efficacy of antimicrobials, to evaluate the ability of natural animal proteins/peptides to kill in vitro
antibiotic-resistant, as well as, -susceptible bacteria, and to determine the effects of key components of animal
digesta (e.g., pH, mineral content, and proteolytic digestive enzymes) on the estimated antimicrobial activity
of these proteins/peptides.
The minimum inhibitory concentrations (MIC) for polymyxin B (control antibiotic) were determined to be
.76, .76, and .90 µg/mL for Escherichia coli, Escherichia coli (nalidixic acid-resistant), and Staphylococcus aureus,
respectively. The intra- and inter-assay variation for MIC determination was .18 and .2%, respectively.
The natural animal proteins and peptides (lactoferrin, lactoferricin B, hen egg lysozyme, and alpha-
lactalbumin LDT2) were determined in in vitro (acetic acid medium) to kill selected bacteria. Each of the
tested proteins/peptides was active against an antibiotic-resistant (nalidixic acid) strain of E. coli; however, the
required concentrations for antimicrobial activity were 10 to 15 times higher than that of the nonantibiotic-
resistant strain. The antimicrobial activity of each protein/peptide in animal digesta fluid was 130 to 300%
greater than that in the acetic acid media. Overall, the intra- and inter-assay variation values for the tested
proteins/peptides was 3 and 3.4%, respectively.
The antimicrobial activity of two of the three proteins/peptides was not affected by the presence of cationic
minerals. The change in pH (digesta fluid and acetic acid media) from 7 to 2 resulted in a loss of antimicrobial
activity of 33% for all proteins/peptides. Therefore, the increase in antimicrobial activity associated with the
digesta fluid is not related to change in H or the mineral concentration of the digesta. Based on these data,
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Summary and Implications
The objectives of this research were to validate the
sensitivity and precision of an in vitro assay for
evaluating the efficacy of antimicrobials, to evaluate the
ability of natural animal proteins/peptides to kill in vitro
antibiotic-resistant, as well as, -susceptible bacteria, and
to determine the effects of key components of animal
digesta (e.g., pH, mineral content, and proteolytic
digestive enzymes) on the estimated antimicrobial activity
of these proteins/peptides.
The minimum inhibitory concentrations (MIC) for
polymyxin B (control antibiotic) were determined to be
.76, .76, and .90 µg/mL for Escherichia coli, Escherichia
coli (nalidixic acid-resistant), and Staphylococcus aureus,
respectively. The intra- and inter-assay variation for MIC
determination was .18 and .2%, respectively.
The natural animal proteins and peptides (lactoferrin,
lactoferricin B, hen egg lysozyme, and alpha-lactalbumin
LDT2) were determined in in vitro (acetic acid medium)
to kill selected bacteria.  Each of the tested
proteins/peptides was active against an antibiotic-resistant
(nalidixic acid) strain of E. coli; however, the required
concentrations for antimicrobial activity were 10 to 15
times higher than that of the nonantibiotic-resistant strain.
The antimicrobial activity of each protein/peptide in
animal digesta fluid was 130 to 300% greater than that in
the acetic acid media.  Overall, the intra- and inter-assay
variation values for the tested proteins/peptides was 3 and
3.4%, respectively.
The antimicrobial activity of two of the three
proteins/peptides was not affected by the presence of
cationic minerals.  The change in pH (digesta fluid and
acetic acid media) from 7 to 2 resulted in a loss of
antimicrobial activity of 33% for all proteins/peptides.
Therefore, the increase in antimicrobial activity
associated with the digesta fluid is not related to change in
pH or the mineral concentration of the digesta.  Based on
these data, natural proteins/peptides represent potential
antibiotic substitutes.
Introduction
With the recent restrictions of antibiotic use in food-
producing animals (European Commission, Dec. 10,
1998), the greater concerns about antibiotic-resistant
bacteria in both the animal and human population and the
desire to reduce foodborne pathogen levels, an increasing
need to develop effective but human and environmental
compatible, antibiotic alternatives for the pork industry
and the medical industry has arisen.
Recently, natural proteins have been identified that
possess these attributes.  In vitro, these proteins have been
shown to be antimicrobial peptides (AMP) or directly
form AMP upon degradation by digestive enzymes,
stimulate endogenous synthesis of AMPs by the animal,
and induce immune responses favorable to bacterial
removal.
Proteins with these characteristics have been
identified as components of milk (e.g., lactoferrin,
lactoferricin, and alpha-lactalbumin), eggs (e.g.,
lysozyme), and animal tissues (e.g., defensins).  These
proteins can function as a natural bacterial barrier for the
pathogen-susceptible neonate, embryo and animal cells or
organs, respectively.
Some AMPs exhibit unique mechanisms for killing
bacteria compared with current antibiotics used in the
pork industry.  These AMPs selectively bind to the outer
lipid membrane of the bacterium and form blisters and
pores, which eventually result in lysis of the cell and
cellular death (12).  AMPs also have the ability to
stimulate the production of IL-1B (11).  The stimulation
of IL-1B would create in increase in chemotaxis of the
neutrophils to that area.  These neutrophils contain AMPs
produced from the animal, which would serve as a
secondary source of AMPs for the host.
Based on these in vitro data, it is hypothesized that
the feeding of these natural proteins results in the enteric
production of antimicrobial peptides, which function as
effective antibiotics via the direct antimicrobial activity of
the peptides, and the peptide’s indirect enhancement of
the immune response of the animals.  Because of their
unique mechanism for killing bacteria, it also is believed
that the AMPs or their precursor may be effective in
killing antibiotic-resistant, as well as antibiotic-sensitive,
bacteria.  However, the antimicrobial efficacy of these
AMPs in vivo, particularly in the animal digestive tract,
has not been defined.
The objectives of this research were to validate the
sensitivity and precision of an in vitro assay for
evaluating the efficacy of antimicrobials, to evaluate the
ability of natural animal proteins/peptides to kill in vitro
antibiotic-resistant, as well as, susceptible bacteria, and to
determine the effects of components of animal digesta
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(e.g., pH, mineral content, and proteolytic digestive




A radial diffusion assay (8) was used.  Briefly,
bacteria were grown overnight for 18 h at 37°C in
trypticase soy broth (TSB).  Midlogarithmic phase
organisms were used by inoculating TSB with the
growing bacteria for an additional 3 h at 37°C.  The
bacteria were centrifuged and washed in cold 10 mM
sodium phosphate buffer (NAPB, pH 7.4) and
resuspended in cold NAPB to achieve an optical density
(620 nm) of 5 × 107 colony forming units (CFU)/mL.  A
volume containing 1 × 106 bacterial CFU was added to 10
mL of melted sterile agarose (10 mM NAPB, 3 mg TSB,
1% w/v of low electroendosmosis-type agarose, and .02%
v/v Tween 20).  After vortexing the bacteria with the agar,
the agar was poured into a 100 × 15-mm petri dish.
A 3-mm-diameter gel punch was used to make 12
evenly spaced wells in solidified agar medium.  The
punch was sterilized between plates to prevent surface
contamination.  Five µL of test or control fluid was added
to each well.  The plates were incubated for 3 h at 37°C,
and then overlaid with 10 mL of sterile agar (6% w/v TSB
and 1% w/v low electroendosmosis-type agarose).
After a 12-h incubation at 37°C, the diameter of the
clear zone surrounding the wells was measured with a 10
× measuring magnifier that contained a metric scale scribe
in .1-mm increments.  The diameter of clearing (clearance
zone) was expressed in units (.1 mm = 1 U) minus the
diameter of the well.
Evaluation of the Sensitivity and Precision of the
Antimicrobial Activity Assay
Each protein/peptide and the control antibiotic was
added to the diluent of choice (acetic acid or digesta) in 5-
serial two-fold dilutions (Table 1).  These dilution
concentrations were determined to give a linear change in
the total diameter clearance.
A regression equation was developed from the serial
dilutions by plotting the known concentrations of a
protein/peptide that was added to the fluid versus the
respective clearance zones.  The regression equation was
then used to determine the minimum inhibitory
concentration (MIC) for each protein/peptide tested.
The intra-assay variations for MIC estimates were
determined by analyzing three samples of each
protein/peptide/antibiotic dilution and determining the
MIC from each sample (three MIC values/day for each
protein/peptide/antibiotic).  The inter-assay variation was
determined by analyzing the three samples of each
protein/peptide dilution on each of four consecutive days.
Bacteria
Two antibiotic-sensitive bacteria, a gram-negative
(Escherichia coli) and a gram-positive (Staphylococcus
aureus) bacteria were used to evaluate the efficacy of
activity of the selected proteins/peptides.  In addition, an
antibiotic-resistant bacterium (Escherichia coli – nalidixic
acid resistant) was evaluated.
Thad Stanton of the National Animal Disease Center
(Ames, IA) donated the antibiotic susceptible strains of E.
coli and S. aureus.  Karl Dawson of Alltech (KY) donated
the non-isogenic Escherichia coli – nalidixic acid
resistant strain.  Prior to usage, the bacteria were stored in
an -80°C freezer.
When using the nalidixic acid-resistant bacteria, 80
µg of nalidixic acid was added to the culture tubes during
growth, and 2 µg of nalidixic acid was added to each 10-
mL tube of low electroendosmosis-type agarose.
Animal Digesta Collection and Recovery
Digesta fluid was collected from 250-pound pigs
killed at the Iowa State University Meat Lab.  Prior to
slaughter, the pigs had been self-fed a fortified corn-
soybean meal diet and were removed from feed 2 h prior
to digesta collection.  The pigs used in the collection had
not been administered (orally or injected) antimicrobial
agents for an extended length of time.  The fluid was
collected from the duodenum and jejunum of the pig and
pooled into one sample.  The contents were centrifuged at
10,000 × g for 20 min.  The supernatant was collected and
then centrifuged again.  This procedure was repeated one
additional time.  The supernatant was then placed in a
sterile syringe and filtered through a series of filters (5,
.45, and .2 µm) and then placed into sterile polypropylene
tubes.
For analysis of the activity of the
proteins/peptides/antibiotic in the digesta fluid, the
proteins/peptides/antibiotic were added to the digesta at a
known level prior to centrifugation.  The antimicrobial
activity from the digesta was then compared with the
same protein/peptide/antibiotic activity in acetic acid.  To
ensure that the peptide activity was not diminished during
processing, known concentrations of each
protein/peptide/antibiotic was added to processed digesta
fluid and then tested for antimicrobial activity compared
with the other digesta samples.
Proteins/Peptides/Antibiotic
Lactoferrin was received from DMV International
Nutritionals (Fraser, NY).  Lactoferricin B and the alpha-
lactalbumin peptide, LDT2 (9), were synthetically
developed by Biopeptide Co., LLC (San Diego, CA).
Hen egg lysozyme was purchased from Sigma (St. Louis,
MO), as well as, the antibiotic control, polymyxin B.
Efficacy of AMP were evaluated for their MIC in
vitro when placed in acetic acid, acetic acid with various
changes reflecting that in the digesta (e.g., pH and mineral
composition), and in swine digesta.
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Effects of components of Animal Digesta on Antimicrobial
Activity of AMPs
Cationic minerals.  The effect of the concentrations
of six cationic minerals (Zn, Mg, Cu, Fe, Na, and K) on
the antimicrobial activity of three proteins/peptides
(lactoferrin, lactoferricin, and lysozyme) on E. coli
(antibiotic-sensitive) were evaluated.  Each
protein/peptide was evaluated in acetic acid at the highest
concentration used in the MIC determination.
Zn (Zn oxide), Mg (Mg oxide), Cu (Cu sulfate), and
Fe (Fe oxide) were individually added to achieve six
concentrations of each mineral (1,2, 3, 4, 5, and 6 mM).
Na (NaCl) and K (KCl) were individually added to
achieve concentrations of 20, 40, 60, 80, and 100 mM.
Typical total and free ion concentrations in the small
intestine of the pig are given in Table 3 (3).
pH.  The effect of pH on the antimicrobial activity of
three proteins/peptides (lactoferrin, lactoferricin, and
lysozyme) on E. coli (antibiotic susceptible) were
evaluated.  Again, each protein/peptide was evaluated at
the highest concentration used in MIC determination.
The antimicrobial activity of each protein/peptide was
evaluated in acetic acid and animal digesta with initial
pHs of 4.4 and 6.5, respectively.  The pH in acetic acid
and digesta was lowered to 2 and 2.4, respectively, by the
addition of 1 N hydrochloric acid (HCl).
Enzyme inhibition.  The effect of protease enzyme
inhibition in digesta fluid on the antimicrobial activity of
three proteins/peptides (lactoferrin, lactoferricin, and
lysozyme) on E. coli (antibiotic-susceptible) were
evaluated.  Again, each protein/peptide was evaluated at
the highest concentration used in MIC determination.
The antimicrobial activity of each protein/peptide was
evaluated through the addition of Pepstatin A, an protease
enzyme inhibitor from Sigma, to digesta samples prior to
any centrifugation process.  Pepstatin A was added at a
concentration of 200 µg/mL digesta fluid.
Results and Discussion
Antimicrobial Assay Sensitivity and Variation
The antibiotic polymyxin B was initially used to
determine the sensitivity and precision of the
antimicrobial activity assay.  The MIC value for
polymyxin B was detected to be .76 ± .17 µg/mL.  The
intra- and inter-assay variation for MIC determination
was .18 and .2%, respectively.
Antimicrobial Efficacy of Proteins/Peptides in In vitro
The use of antimicrobial proteins/peptides in the in
vitro assay verified that these products do in fact kill
selected bacteria (Table 2), and that AMPs possess the
ability to kill antibiotic-resistant bacteria.  MIC values for
each protein/peptide are presented in Table 2.
The antibiotic-resistant strain of E. coli required
AMP concentrations 10 to 15 times higher than that of the
nonantibiotic-resistant strain.  However, the two E. coli
strains are not isogenic, which implies that the nalidixic
acid-resistant bacteria has a different genetic makeup than
the susceptible bacteria and has the potential to possess a
unique response to the proteins/peptides.  The greater
concentration of the proteins/peptides needed to kill
antibiotic-resistant bacteria could be due to some external
membrane changes that reduce protein/peptide binding
(e.g. alteration in molecular charges or decrease in certain
fatty acids required for AMP binding).
The fact that not all of the peptides work on gram-
positive bacteria is indicative of a similar change in
membrane structure that is associated with the antibiotic
resistant bacteria.  This type of hypothesis is obvious
when evaluating the antimicrobial activity of the alpha-
lactalbumin peptide on the resistant strain of E. coli.
Although the peptide does not work on the other bacteria,
it does produce a killing effect on the resistant E. coli.
This could be due to a membrane alteration that allows
the peptide to bind and lyse the bacterium.
In general, the MIC values achieved in the
researchers’ laboratory were slightly lower than the
literature values (1-2, 4-6, 9-11).  The increase in
antimicrobial activity could be associated with the
characteristics of each protein or peptide evaluated,
because the isolation procedures used can have an impact
on activity due to differences in peptide configuration or
presence of additional components, such as iron.
Overall, the intra-assay variation values for the
lactoferrin, lactoferricin, and lysozyme were 8.7, .21, and
2.6%, respectively.  The inter-assay variation values for
the lactoferrin, lactoferricin, and lysozyme were 10.4, .70,
and 2.3%, respectively.
Due to the fact that the alpha-lactalbumin peptide
LDT2 had no effect on E. coli in the MIC test, it was not
evaluated for the mineral, pH, or digesta fluid tests.  The
possible reasons that LDT2 did not work against either E.
coli or S. aureus is that the peptide has been reported to
only work against gram-positive bacteria (S. aureus); and
that recent evidence has indicated that the peptide, as well
as its protein precursor, must be present in at least dimer
formation.  Because the peptide was synthesized and
purified, it is most likely not in dimer formation.
Effects of Components in Intestinal Digesta on
Antimicrobial Efficacy of Proteins/Peptides In vitro
Overall, the various minerals added to acetic acid
either had no effect on lactoferrcin or lysozyme; however,
there was reduced antimicrobial activity of the protein,
lactoferrin (Table 3).  In addition, as the Zn concentration
increased, the lactoferrin antimicrobial activity returned to
a level similar to that of the acetic acid control.
Other literature has indicated a positive effect of
cationic minerals on increasing antimicrobial activity of
lactoferricin (1).  The increase in antimicrobial activity
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that Bellamy et al. (1) discusses could be due to the fact
that proteins/peptides are drawn to the cation/anion
charges of certain minerals.
Upon exposing the peptides to a pH of 2 (similar to
that of the stomach), the activity of the proteins/peptides
was reduced to approximately 67% of that of a pH of 7
(Table 4).  This response would be expected, because the
lowering of the pH should alter the charges on various
amino acids, which would change the proteins/peptides
ability to bind bacteria.  Kuwata et al. (7) demonstrates
that lactoferrin can survive the pH of the human stomach;
however, lactoferrin is cleaved by digestive enzymes
during this process.  Since some of the lactoferrin and its
activity is retained in the study, one would assume that
the disulfide bridges aid in preventing the
proteins/peptides from becoming denatured when exposed
to a lower pH.
The addition of the antimicrobial proteins/peptides to
digesta fluid created antimicrobial activity greater (up to
twice as great) than the values given in Table 2 (Table 5).
However, digesta fluid without the addition of AMPs had
no antimicrobial activity.
One would expect the increase in activity with a
protein that would be degraded into its more active
peptide through pepsin and trypsin cleavage; however,
this increase in antimicrobial activity was also associated
with the peptides which have already been cleaved.  The
increase antimicrobial activity would indicate that there
are additional factors within the digesta fluid (possibly
other trace minerals or a synergistic effect with a
combination of minerals, digesta peptides not filtered out)
that enhance the antimicrobial activity of the
proteins/peptides.
The inhibition of digestive enzymes did not alter the
increase in protein/peptide activity compared with the
activity of these products in untreated digesta fluid.  This
result would support the previous comment in that the
change in activity is not entirely due to an enzymatic
cleaving of the protein that would result in higher
antimicrobial activity.
Because the addition of selected minerals did not
affect the antimicrobial activity of these proteins/peptides,
and in some cases, slightly decreased activity, one would
assume that the increase in activity in the digesta was not
associated with the mineral composition of the digesta or
the respective corn-soybean meal diet the pigs were fed
prior to slaughter.
The fact that the nutrient concentration of certain
minerals in the digesta, digestive enzymes, and pH did not
alter the antimicrobial activity in the in vitro studies
indicates that other factors likely are contributing to the
enhanced antimicrobial activity of the proteins/peptides in
animal digesta.
In conclusion, the antimicrobial radial diffusion assay
has been shown to be a highly sensitive and precise assay
for evaluated antimicrobial activity with low intra- and
inter-assay variation.  Furthermore, natural
proteins/peptides from milk and eggs have been shown to
elicit antimicrobial activity against antibiotic-susceptible
and -resistant bacteria both in acetic acid and digesta fluid
media.
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Bacteria Status Polymyxin B Lactoferrin Lactoferricin LDT2 Lysozyme
E. coli Susceptible .76 ± .17 6.4 ± 1.2 2.15 ± .34 No effect 7.06 ± .68
E. coli Resistant .76 ± .18 100 ± 13.1 20 ± 2.2 250 ± 18.6 100 ± 15.3
S. aureus Susceptible .90 ± .20 No effect 2.10 ± .34 No effect No effect
Range tested found to be linear.
Mean of 12 samples ± SEM.
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Table 3.  Effects of mineral concentrations on antimicrobial activity of proteins/peptides. Values reported as diameter
of clearing expressed in units (.1 mm = 1 U) with standard errors.
Mineral (mM) Lactoferrin Lactoferricin Lysozyme
Acetic acid Total in digesta Free in digesta (3,000 µg/mL) (50 µg/mL) (250 µg/mL)
Acetic acid control 360 ± 21 550 ± 19 580 ± 33
Zn .710 .11
1 140 ± 10 50 ± 0 650 ± 0
2 200 ± 0 530 ± 30 650 ± 0
3 275 ± 25 530 ± 10 600 ± 50
4 290 ± 10 510 ± 10 600 ± 50
5 335 ± 25 510 ± 0 570 ± 30
6 310 ± 10 525 ± 5 585 ± 35
Mg 15.7 6.4
1 125 ± 5 515 ± 5 510 ± 40
2 205 ± 5 540 ± 0 570 ± 70
3 245 ± 5 530 ± 0 640 ± 0
4 335 ± 55 555 ± 5 645 ± 95
5 305 ± 5 555 ± 5 705 ± 25
6 310 ± 10 530 ± 10 665 ± 15
Fe 2.33 .02
1 50 ± 15 555 ± 5 645 ± 5
2 50 ± 10 530 ± 10 655 ± 5
3 155 ± 5 545 ± 5 640 ± 0
4 145 ± 5 560 ± 0 625 ± 5
5 120 ± 0 565 ± 15 625 ± 5
6 145 ± 15 565 ± 5 635 ± 5
Ca 46.1 5.2
1 145 ± 5 540 ± 0 575 ± 25
2 150 ± 10 565 ± 15 550 ± 20
3 155 ± 5 555 ± 5 625 ± 25
4 145 ± 5 530 ± 10 615 ± 35
5 150 ± 0 560 ± 10 650 ± 50
6 170 ± 10 555 ± 5 660 ± 10
NaCla 138 116.8
20 100 ± 0 530 ± 10 625 ± 25
40 85 ± 15 545 ± 5 540 ± 10
60 90 ± 0 525 ± 5 560 ± 10
80 95 ± 5 555 ± 5 545 ± 5
100 100 ± 0 530 ± 10 565 ± 15
KCla 30.4 26.7
20 120 ± 10 535 ± 10 540 ± 25
40 90 ± 15 550 ± 5 580 ± 15
60 100 ± 10 540 ± 10 560 ± 10
80 110 ± 5 545 ± 15 555 ± 0
100 95 ± 0 550 ± 10 550 ± 5
a NaCl and KCl levels for digesta are reported as Na and K ions, not the salt concentrations
Values reported as means ± SEM.
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Table 4.  Effect of digesta fluid on antimicrobial activity of proteins/peptides and an antibiotic.  Values reported as
diameter of clearing expressed in units (.1 mm = 1 U) and percentage of antimicrobial activity in digesta relative to
that in acetic acid control.
Assay Media
Antibiotic/ Relative Antimicrobial
Protein/Peptide  (µg/mL) Acetic Acid Digesta Fluid  Activity
Lactoferrin 6000 250 ± 0 1,097 ± 3.3 439
Lactoferricin 50 300 ± 0 710 ± 5.8 237
Lysozyme 250 690 ± 0 817 ± 8.8 118
Polymyxin B   1200   750 ± 0     240 ± 13.3 32
Means reported from three samples ± SEM.
Table 5.  Effect of pH on antimicrobial activity of proteins/peptides and an antibiotic.  Values reported as diameter of
clearing expressed in units (.1 mm = 1 U) and percentage antimicrobial activity in digesta relative to that in acetic acid
control.
Acetic Acid Digesta Fluid
Antibiotic/      %       %
Protein/Peptide  (µg/mL) pH 4.4 pH 2 Activity pH 6.5 pH 2.4  Activity
Lactoferrin 6000 250 ± 0 177 ± 26.7 71 1097 ± 3.3 393 ± 23.3 36
Lactoferricin     50 300 ± 0 150 ± 0 50 710 ± 5.8 323 ± 8.6 45
Lysozyme   250 690 ± 0 603 ± 3.3 87 817 ± 8.8 710 ± 13.3 87
Polymyxin B 1200 750 ± 0 673 ± 13.3 90 240 ± 13.3 240 ± 0 100
Means reported from three samples ± SEM.
